Pramodini Medicare Ltd, incorporated in 2000, is a diagnostic service provider in India offering technology-enabled healthcare services across radiology, clinical laboratory, and nuclear medicine segments.
The company serves a wide range of clients, including public and private hospitals, PSUs, medical colleges, and standalone diagnostic centres, across Tier I, II, and III cities.
Its service portfolio includes radiology services such as MRI, CT scans, X-rays, ultrasound with colour Doppler, mammography, DEXA scans, and interventional radiology. In clinical diagnostics, it offers services in haematology, microbiology, immunology, pathology, and biochemistry, as well as nuclear medicine services such as PET-CT, SPECT, and nuclear therapy. The company also operates a 24x7 teleradiology unit and a processing laboratory in Vijayawada.
Business Model
The company operates through multiple models:
Public-Private Partnerships (PPP) with government hospitals and teaching institutions
Private partnerships with hospitals
Strategic tie-ups with PSUs
Standalone private diagnostic centres
Operations & Workforce
As of December 31, 2025, the company operated 15 diagnostic centres across 6 states: Uttar Pradesh, Andhra Pradesh, Karnataka, West Bengal, Haryana/NCR Delhi, and Kerala (yet to commence operations), covering 13 cities.
During the same period, the company had a workforce of 134 permanent employees and 15 contractual staff, supporting its operations and service delivery.
Competitive Strengths
Diversified diagnostic services across multiple healthcare segments
Presence across Tier I, II, and III cities
Multiple operating models, including PPP and private partnerships
Integrated service offerings across radiology, pathology, and nuclear medicine
Established operational presence with a growing network of centres
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 50% | -- |
| Non-Institutional Investors (NIIs) | 35% | -- |
| Retail Individual Investors (RIIs) | 15% | -- |
Pramodini Medicare’s total income 0.00 by 0.00% and total expenses 1,738.26 by -12.66%, resulting in an EBITDA 2,116.37 by 33.18% and a profit after tax (PAT) 0.00 by 0.00% between March 31, 2025 and March 31, 2026.
1,738.2631 March 2026 | 1,990.3231 March 2025 | 1,607.2131 March 2024 |
2,116.3731 March 2026 | 1,589.0831 March 2025 | 1,488.7231 March 2024 |
2,116.37
1,905
1,693
1,481
1,270
1,058
847
635
423
212
0.00
Diversified diagnostic service portfolio across radiology.
Pathology
and nuclear medicine.
Presence across multiple states and cities.
Asset-light PPP and partnership-based business models.
Strong profitability margins.
Experienced promoter group and management team.
Technology-enabled diagnostic services including 24x7 teleradiology.
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| -- | -- | -- |
| Issue Composition: | |
|---|---|
| Face Value | ₹10 per share |
| Total Issue Size | 0 shares (aggregating up to To be announced) |
| Fresh Issue | 0 shares (aggregating up to To be announced) |
| Offer for Sale | 0 shares of ₹10 (aggregating up to To be announced) |
| Issue Type | Book building |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | 85.71 shares |
| Post-Issue Shareholding | 0 shares |
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Pramodini Medicare ipo has been designed to ensure broad participation while maintaining optimal price discovery.
D No:- 29-4-54 K C S I Complex Prakasam Road Vijayawada
Purva Sharegistry (India) Pvt.Ltd.
| Book Running Lead Manager(s) |
|---|
| Smart Horizon Capital Advisors Pvt Ltd |